Faculty

Needs Statement

Higher opioid prescribing puts patients at risk for addiction and overdose. According to the CDC (2016) since 1999 more than 165,000 people have died of an overdose related to prescription opioids and as many as 1 in 4 persons with chronic pain treated in primary care are prescribed opioids (approximately 50% of all prescribed opiates) and struggle with addiction. But chronic pain is also a significant issue. About 11% of Americans struggle with daily (chronic) pain. There is insufficient evidence that prescription opioids control chronic pain effectively over the long term, and there is evidence that other treatments can be effective with less harm. The need for alternative strategies from opiates for pain management and clear guidelines for use of opiates for chronic pain when no alternatives exist have led the CDC to develop Guidelines for Prescribing Opiates for Chronic Pain (2016). Safe treatment and monitoring strategies are discussed and at the end of this activity participants should be able to:

1. Identify Non-opioid treatment modalities for pain
2. Discuss non-opiate medications and potential risks associated with their use for chronic pain
3. Apply guiding principles for treating chronic pain with and without opiates
4. Compare qualitative versus quantitative urine drug screens
5. Develop a controlled substance agreement using typical components

Target Audience

Healthcare professionals in a primary care setting.

Objectives

At the end of this presentation participants should be able to:

1. Identify Non-opioid treatment modalities for pain
2. Discuss non-opiate medications and potential risks associated with their use for chronic pain
3. Apply guiding principles for treating chronic pain with and without opiates
4. Compare qualitative versus quantitative urine drug screens
5. Develop a controlled substance agreement using typical components

Accreditation

In support of improving patient care, University of Kentucky HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CME
This enduring material is designated for a maximum of 1.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

This training has been approved by the KBML as meeting the statutory requirements of HB1. 0521-H1.0-UK14C

ACGME Competencies

• Patient care
• Medical knowledge
• Practice-based learning and improvement
• Interpersonal and communication skills
• Professionalism
• Systems-based practice

IPE Competencies

• Values/Ethics for Interprofessional Practice
• Roles/ Responsibilities
• Interprofessional Communication
• Teams and Teamwork

CPE
This -based activity will award 1.75 contact hours (0.175 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers.

CNE
The University of Kentucky, College of Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC).

This educational activity is offered for a maximum of 1.75 ANCC contact hours.

The Kentucky Board of Nursing (KBN) approves The University of Kentucky, College of Nursing (UKCON) as a provider as well. ANCC and KBN approval of a continuing nursing education provider does not constitute endorsement of program content nor commercial sponsors. The University of Kentucky does not approve commercial products. This educational activity is offered for a maximum of 2.1 KBN contact hours.

Provider #: 3-0008-12-21-0057. In order to receive credit, participants complete this CNE activity and submit a credit application and evaluation form online. Certificates may be printed once the evaluation is completed.

Other
UK Healthcare CECentral certifies this activity for 1.75 hours of participation.

KBSW
This activity has been approved by the Kentucky Board of Social Work for 1.75 hours.

Faculty Disclosure

All planners, faculty, and others in control of educational content are required to disclose all their financial relationships with ineligible companies within the prior 24 months.  An ineligible company is defined as one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if the educational content an individual can control is related to the business lines or products of the ineligible company.

None of the planners, faculty, and others in control of educational content for this educational activity have relevant financial relationship(s) to disclose with ineligible companies.

The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses.

Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

Acknowledgment

The activity is supported by Anthem.